SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

PENA, Melissa S. Burroughs; ABDALA, Carmen Verônica Mendes; SILVA, Luis Carlos  and  ORDUNEZ, Pedro. Usefulness for surveillance of hypertension prevalence studies in Latin America and the Caribbean: the past 10 years. Rev Panam Salud Publica [online]. 2012, vol.32, n.1, pp. 15-21. ISSN 1020-4989.  http://dx.doi.org/10.1590/S1020-49892012000700003.

    1. United Nations General Assembly. Sixty- Sixth Sessions. Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control on Non-communicable Diseases. A/66/L. 1. New York: United Nations; 2011. Available from: http://daccess-dds-ny.un.org/doc/UNDOC/LTD/N11/497/77/PDF/N1149777.pdf? Open Element Accessed 16 September 2011. [ Links ]

    2. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: WHO; 2011. [ Links ]

    3. Perel P, Casas JP, Ortiz Z, Miranda JJ. Noncommunicable disease and injuries in Latin America and the Caribbean: time for action. PLoS Med. 2006;3(9):1148-51. [ Links ]

    4. Anderson GF, Chu E. Expanding priorities- confronting chronic disease in countries with low income. N Engl J Med. 2007;356(3):209-11. [ Links ]

    5. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P, et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377(9775):1438-47. [ Links ]

    6. Miranda JJ, Kinra S, Casas JP, Davey Smith G, Ebrahim S. Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health. 2008;13(10):1225-34. [ Links ]

    7. Abegunde DO, Mathers CD, Adam T, Ortegon M, Strong K. The burden and costs of chronic diseases in low-income and middle-income countries. Lancet. 2007;370(9603):1929-38. [ Links ]

    8. Anand SS, Yusuf S. Stemming the global tsunami of cardiovascular disease. Lancet. 2011;377(9765):529-32. [ Links ]

    9. Bonita R. Strengthening NCD prevention through risk factor surveillance. Glob Health Action. 2009;2(S1):4-6. [ Links ]

    10. Castillo-Salgado C. Trends and directions of global public health surveillance. Epidemiol Rev. 2010;32(1):93-109. [ Links ]

    11. Pan American Health Organization. Implementation of the regional strategy and plan of action for an integrated approach to the prevention and control of chronic diseases, including diet, physical activity and health. CD50/INF/6. Washington, D.C.: PAHO; 2010. Available from: http://new.paho.org/hq/dmdocuments/2010/CD50-INF-6-F-e.pdf Accessed 23 August 2011. [ Links ]

    12. Ordúñez P, Silva LC, Rodríguez MP, Robles S. Prevalence estimates for hypertension in Latin America and the Caribbean: are they useful for surveillance? Rev Panam Salud Publica. 2001;10(4):226-31. [ Links ]

    13. Silva LC, Ordúñez P, Rodríguez MP, Robles S. A tool for assessing the usefulness of prevalence studies done for surveillance purposes: the example of hypertension. Rev Panam Salud Publica. 2001;10(3):152-60. [ Links ]

    14. Carbajal HA, Salazar MR, Riondet B, Rodrigo HF, Quaini SM, Rechifort V, et al. Variables asociadas a hipertensión arterial en una region de la Argentina. Medicina (Buenos Aires). 2001;61(6):801-9. [ Links ]

    15. Hernández-Hernández R, Silva H, Velasco M, Pellegrini F, Macchia A, Escobedo J, et al. Hypertension in seven Latin American cities: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study. J Hypertens. 2010;28(1):24-34. [ Links ]

    16. Sichieri R, Oliveira MC, Pereira RA. High prevalence of hypertension among black and mulatto women in a Brazilian survey. Ethn Dis. 2001;11(3):412-8. [ Links ]

    17. Barreto SM, Passos VMA, Firmo JOA, Guerra HL, Vidigal PG, Lima-Costa MFF. Hypertension and clustering of cardiovascular risk factors in a community in southeast Brazil- Bambuí Health and Ageing Study. Arq Bras Cardiol. 2001;77(6):576-81. [ Links ]

    18. Freitas OC, Carvalho FR, Neves JM, Veludo PK, Parreira RS, Goncalves RM, et al. Prevalence of hypertension in the urban population of Catanduva, in the state of Sao Paulo, Brazil. Arq Bras Cardiol. 2001;77(1):9-21. [ Links ]

    19. Oliveira RZ, Nogueira JL. Hipertensão arterial no município de Cianorte, estado do Paraná, Brasil. Acta Sci Health Sci. 2003;25(1):75-9. [ Links ]

    20. Feijão AMM, Gadelha FV, Bezerra AA, Oliveira AM, Silva MSS, Lima JWO. Prevalência de excesso de peso e hipertensão arterial, em população urbana de baixa renda. Arq Bras Cardiol. 2005;84(1):29-33. [ Links ]

    21. Wiehe M, Fuchs SC, Moreira LB, Moraes RS, Pereira GM, Gus M, et al. Absence of association between depression and hypertension: results of a prospectively designed population-based study. J Hum Hypertens. 2006;20(6):434-9. [ Links ]

    22. Pereira MR, Coutinho MSSA, Freitas PF, D'Orsi E, Bernardi A, Hass R. Prevalência, conhecimento, tratamento e controle de hipertensão arterial sistêmica na população adulta urbana de Tubarão, Santa Catarina, Brasil, em 2003. Cad Saúde Pública. 2007;23(10):2363-74. [ Links ]

    23. Hartmann M, Dias-da-Costa JS, Olinto MTA, Pattussi MP, Tramontini A. Prevalência de hipertensão arterial sistêmica e fatores associados: um estudo de base populacional em mulheres no Sul do Brasil. Cad Saúde Pública. 2007;23(8):1857-66. [ Links ]

    24. Barbosa JB, Silva AA, Santos AM, Monteiro Junior FC, Barbosa MM, Barbosa MM, et al. Prevalence of arterial hypertension and associated factors in adults in São Luís, state of Maranhão. Arq Bras Cardiol. 2008;91(4):236-42,260-6. [ Links ]

    25. Cesarino CB, Cipullo JP, Martin JF, Ciorlia LA, Godoy MR, Cordeiro JA, et al. Prevalence and sociodemographic factors in a hypertensive population in São José do Rio Preto, São Paulo, Brazil. Arq Bras Cardiol. 2008;91(1):29-35. [ Links ]

    26. Chrestani MAD, Santos IS, Matijasevich AM. Hipertensão arterial sistêmica auto-referida: validação diagnóstica em estudo de base populacional. Cad Saúde Pública. 2009;25(11):2395-406. [ Links ]

    27. Longo GZ, Neves J, Luciano VM, Peres MA. Prevalence of high blood pressure levels and associated factors among adults in southern Brazil. Arq Bras Cardiol. 2009;93(4):387-94,380-6. [ Links ]

    28. Nascente FMN, Jardim PCBV, Peixoto MRG, Monego ET, Barroso WKS, Moreira HG, et al. Hipertensão arterial e sua associação com índices antropométricos em adultos de uma cidade de pequeno porte do interior do Brasil. Rev Assoc Med Brás. 2009;55(6):716-22. [ Links ]

    29. Rosário TM, Scala LCN, França GVA, Pereira MRG, Jardim PCBV. Prevalência, controle e tratamento da hipertensão arterial sistêmica em Nobres-MT. Arq Bras Cardiol. 2009;93(6):672-8. [ Links ]

    30. Cipullo JP, Martin JF, Ciorlia LA, Godoy MR, Cacao JC, Loureiro AA, et al. Prevalência e fatores de risco para hipertensão em uma população urbana Brasileira. Arq Bras Cardiol. 2010;94(4):519-26. [ Links ]

    31. Fasce E, Campos I, Ibáñez P, Flores M, Zárate H, Román O, et al. Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile. J Hypertens. 2007;25(9):1807-11. [ Links ]

    32. Bautista LE, Vera-Cala LM, Villamil L, Silva SM, Peña IM, Luna LV. Factores de riesgo asociados con la prevalencia de hipertensión arterial en adultos de Bucaramanga, Colombia. Salud Pública Méx. 2002;44(5):399-405. [ Links ]

    33. Ordúñez P, Barceló A, Bernal JL, Espinosa A, Silva LC, Cooper RS. Risk factors associated with uncontrolled hypertension: findings from the baseline CARMEN survey in Cienfuegos, Cuba. J Hypertens. 2008;26(4):663-71. [ Links ]

    34. Atallah A, Kelly-Irving M, Zouini N, Ruidavets JB, Inamo J, Lang T. Controlling arterial hypertension in the French West Indies: a separate strategy for women? Eur J Public Health. 2010;20(6):665-70. [ Links ]

    35. Jean-Baptiste ED, Larco P, Charles-Larco N, Vilgrain C, Simon D, Charles R. Glucose intolerance and other cardiovascular risk factors in Haiti (PREDIAH). Diabetes Metab. 2006;32(5 Pt 1):443-51. [ Links ]

    36. Merle S, Pierre-Louis K, Rosine J, Cardoso T, Inamo J, Deloumeaux J. Prévalence de l'hypertension artérielle en population générale à la Martinique. Rev Epidemiol Sante Publique. 2009;57(1):17-23. [ Links ]

    37. Medina Lezama J, Chirinos Medina J, Zea Díaz H, Morey Vargas O, Bolaños Salazar J, Cuba Bustinza C, et al. Aspectos epidemiológicos y hemodinámicos de la hipertensión y de la prehipertensión arterial en Arequipa. Resultados del estudio prevención. Rev Peru Cardiol (Lima). 2009;35(1):30-43. [ Links ]

    38. Bakris G, Hill M, Mancia G, Steyn K, Black HR, Pickering T, et al. Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action. J Hum Hypertension. 2008;22(1):63-70. [ Links ]

    39. Centers for Disease Control and Prevention. Vital signs: prevalence, treatment and control of hypertension-United States, 1999-2002 and 2005-2008. MMWR Morb Mortal Wkly Rep. 2011;60(4);103-8. [ Links ]

    40. Gaziano TA, Galea G, Reddy KS. Scaling up interventions for chronic disease prevention: the evidence. Lancet. 2007;370(9603):1939-46. [ Links ]

    41. Bonita R. Guest editorial: strengthening NCD prevention through risk factor surveillance. Global Health Action. 2009;2(S1):4-6. [ Links ]

    42. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010;362(7):590-9. [ Links ]

    43. Jafar TH, Islam M, Bux R, Poulter N, Hatcher J, Chaturvedi N, et al. Cost-effectiveness of community-based strategies for blood pressure control in a low-income developing country: findings from cluster-randomized, factorialcontrolled trial. Circulation. 2011;124:1615-25. [ Links ]